Smoking associates with visceral fat accumulation especially in women

Circulation Journal

Volumn 78, Issue 5, 2014, Pages 1259-1263

  Nakanishi, Kaori ^a   Nishida, Makoto ^a   Ohama, Tohru ^a   Moriyama, Toshiki ^a   Yamauchi Takihara, Keiko ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Intima media thickness; Metabolic syndrome; Smoking; Visceral fat; Women

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; TRIACYLGLYCEROL;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN EXPERIMENT; IMPEDANCE; INTRAABDOMINAL FAT; LIFESTYLE; LIPID STORAGE; MALE; METABOLIC SYNDROME X; SMOKING; SYSTOLIC BLOOD PRESSURE;

EID: 84899619420     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-13-1134     Document Type: Article

References (33)

1. Burns DM. Epidemiology of smoking-induced cardiovascular disease. Prog Cardiovasc Dis 2003; 46: 11-29.
2. Erhardt L. Cigarette smoking: An undertreated risk factor for cardiovascular disease. Atherosclerosis 2009; 205: 23-32.
3. Roca M, Roca IC, Mihaescu T. Lung cancer: A comorbidity in chronic obstructive pulmonary disease. Rev Med Chir Soc Med Nat Iasi 2012; 116: 1055-1062.
4. Viswanath K, Herbst RS, Land SR, Leischow SJ, Shields PG, Writing Committee for the ATFoT, Cancer. Tobacco and cancer: An American Association for Cancer Research policy statement. Cancer Res 2010; 70: 3419-3430.
5. World Health Organization. Tobacco or health: A global status report. Geneva: WHO, 1997.
6. Mackay J, Amos A. Women and tobacco. Respirology 2003; 8: 123-130.
7. Fruchart JC, Nierman MC, Stroes ES, Kastelein JJ, Duriez P. New risk factors for atherosclerosis and patient risk assessment. Circulation 2004; 109(Suppl 1): III15-III19.
8. Grundy SM. Metabolic syndrome scientific statement by the American Heart Association and the National Heart, Lung, and Blood Institute. Arterioscler Thromb Vasc Biol 2005; 25: 2243-2244.
9. Kishida K, Funahashi T, Matsuzawa Y, Shimomura I. Visceral adiposity as a target for the management of the metabolic syndrome. Ann Med 2012; 44: 233-241.
10. Mathur SK, Jain P, Mathur P, Punjabi P, Agarwal A, Sharma A. Transcriptomic analysis of visceral adipose from healthy and diabetic obese subjects. Indian J Endocrinol Metab 2013; 17: 446-450.
11. Rosenquist KJ, Pedley A, Massaro JM, Therkelsen KE, Murabito JM, Hoffmann U, et al. Visceral and subcutaneous fat quality and cardiometabolic risk. JACC Cardiovasc Imaging 2013; 6: 762-771.
12. Rothney MP, Catapano AL, Xia J, Wacker WK, Tidone C, Grigore L, et al. Abdominal visceral fat measurement using dual-energy X-ray: Association with cardiometabolic risk factors. Obesity (Silver Spring) 2013; 21: 1798-1802.
13. Yamashita K, Kondo T, Osugi S, Shimokata K, Maeda K, Okumura N, et al. The significance of measuring body fat percentage determined by bioelectrical impedance analysis for detecting subjects with cardiovascular disease risk factors. Circ J 2012; 76: 2435-2442.
14. Kawano H, Soejima H, Kojima S, Kitagawa A, Ogawa H, Japanese Acute Coronary Syndrome Study I. Sex differences of risk factors for acute myocardial infarction in Japanese patients. Circ J 2006; 70: 513-517.
15. Resnick HE, Jones K, Ruotolo G, Jain AK, Henderson J, Lu W, et al. Strong Heart S. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic american indians: The Strong Heart Study. Diabetes Care 2003; 26: 861-867.
16. Yun JE, Won S, Sung J, Jee SH. Impact of metabolic syndrome independent of insulin resistance on the development of cardiovascular disease. Circ J 2012; 76: 2443-2448.
17. Dzien A, Dzien-Bischinger C, Hoppichler F, Lechleitner M. The metabolic syndrome as a link between smoking and cardiovascular disease. Diabetes Obes Metab 2004; 6: 127-132.
18. Ishizaka N, Ishizaka Y, Nagai R, Toda E, Hashimoto H, Yamakado M. Association between serum albumin, carotid atherosclerosis, and metabolic syndrome in Japanese individuals. Atherosclerosis 2007; 193: 373-379.
19. Sanada S, Nishida M, Ishii K, Moriyama T, Komuro I, Yamauchi- Takihara K. Smoking promotes subclinical atherosclerosis in apparently healthy men: 2-year ultrasonographic follow-up. Circ J 2012; 76: 2884-2891.
20. Matsushita Y, Nakagawa T, Yamamoto S, Takahashi Y, Yokoyama T, Noda M, et al. Associations of visceral and subcutaneous fat areas with the prevalence of metabolic risk factor clustering in 6,292 Japanese individuals: The Hitachi Health Study. Diabetes Care 2010; 33: 2117-2119.
21. Ryo M, Maeda K, Onda T, Katashima M, Okumiya A, Nishida M, et al. A new simple method for the measurement of visceral fat accumulation by bioelectrical impedance. Diabetes Care 2005; 28: 451-453.
22. Nishida M, Moriyama T, Ishii K, Takashima S, Yoshizaki K, Sugita Y, et al. Effects of IL-6, adiponectin, CRP and metabolic syndrome on subclinical atherosclerosis. Clin Chim Acta 2007; 384: 99-104.
23. Karastergiou K, Smith SR, Greenberg AS, Fried SK. Sex differences in human adipose tissues: The biology of pear shape. Biol Sex Differ 2012; 3: 13.
24. Kanaley JA, Sames C, Swisher L, Swick AG, Ploutz-Snyder LL, Steppan CM, et al. Abdominal fat distribution in pre- and postmenopausal women: The impact of physical activity, age, and menopausal status. Metabolism 2001; 50: 976-982.
25. Kotani K, Tokunaga K, Fujioka S, Kobatake T, Keno Y, Yoshida S, et al. Sexual dimorphism of age-related changes in whole-body fat distribution in the obese. Int J Obes Relat Metab Disord 1994; 18: 207-212.
26. Pascot A, Lemieux S, Lemieux I, Prud'homme D, Tremblay A, Bouchard C, et al. Age-related increase in visceral adipose tCir and body fat and the metabolic risk profile of premenopausal women. Diabetes Care 1999; 22: 1471-1478.
27. Examination Committee of Criteria for 'Obesity Disease' in Japan, Japan Society for the Study of Obesity. New criteria for 'obesity disease' in Japan. Circ J 2002; 66: 987-992.
28. Janssen I, Heymsfield SB, Allison DB, Kotler DP, Ross R. Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal subcutaneous, and visceral fat. Am J Clin Nutr 2002; 75: 683-688.
29. Camhi SM, Bray GA, Bouchard C, Greenway FL, Johnson WD, Newton RL, et al. The relationship of waist circumference and BMI to visceral, subcutaneous, and total body fat: Sex and race differences. Obesity (Silver Spring) 2011; 19: 402-408.
30. Carroll JF, Chiapa AL, Rodriquez M, Phelps DR, Cardarelli KM, Vishwanatha JK, et al. Visceral fat, waist circumference, and BMI: Impact of race/ethnicity. Obesity (Silver Spring) 2008; 16: 600-607.
31. Komiya H, Mori Y, Yokose T, Tajima N. Smoking as a risk factor for visceral fat accumulation in Japanese men. Tohoku J Exp Med 2006; 208: 123-132.
32. Nguyen AB, Rohatgi A, Garcia CK, Ayers CR, Das SR, Lakoski SG, et al. Interactions between smoking, pulmonary surfactant protein B, and atherosclerosis in the general population: The Dallas Heart Study. Arterioscler Thromb Vasc Biol 2011; 31: 2136-2143.
33. McKinlay SM, Bifano NL, McKinlay JB. Smoking and age at menopause in women. Ann Intern Med 1985; 103: 350-356.